Xue Liangliang, E Linning, Wu Zhifeng, Guo Dongqiang
Department of Radiology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Taiyuan, China.
Front Surg. 2022 Jun 9;9:898965. doi: 10.3389/fsurg.2022.898965. eCollection 2022.
To observe the application value of gastroenterography combined with CT in the evaluation of short-term efficacy and prognosis in patients with esophageal cancer radiotherapy.
From January 2013 to December 2020, the clinical data of 207 patients with esophageal cancer treated by radiotherapy in our hospital were collected retrospectively. All patients received gastroenterography and CT examination before and after radiotherapy, and the patients were followed-up for 1 year, and the evaluation value of their short-term efficacy and prognosis was observed.
After radiotherapy, the length diameter, short diameter, and volume of the lymph node were lower than those before radiotherapy ( < 0.05), but the maximum tube wall thickness had no significant difference ( > 0.05). The length diameter, short diameter, and volume of the lymph node, and the maximum tube wall thickness in the good efficacy group and the good prognosis group were lower, and the objective response rate in the good prognosis group was higher ( < 0.05). The area under the curve (AUC) of the length diameter, short diameter, and volume of the lymph node to evaluate the short-term efficacy of patients with esophageal cancer was 0.738, 0.705, and 0.748, respectively, and the AUC to evaluate the prognosis of patients with esophageal cancer was 0.751, 0.776, and 0.791, respectively.
Gastroenterography combined with CT has a good application value in the evaluation of short-term efficacy and prognosis in patients with esophageal cancer radiotherapy.
观察胃肠造影联合CT在评估食管癌放疗患者短期疗效及预后中的应用价值。
回顾性收集2013年1月至2020年12月我院收治的207例食管癌放疗患者的临床资料。所有患者在放疗前后均接受胃肠造影及CT检查，并对患者进行1年随访，观察其短期疗效及预后的评估价值。
放疗后，淋巴结的长径、短径及体积均低于放疗前（<0.05），但最大管壁厚度差异无统计学意义（>0.05）。疗效好组及预后好组的淋巴结长径、短径及体积，以及最大管壁厚度均较低，预后好组的客观缓解率较高（<0.05）。评估食管癌患者短期疗效的淋巴结长径、短径及体积的曲线下面积（AUC）分别为0.738、0.705及0.748，评估食管癌患者预后的AUC分别为0.751、0.776及0.791。
胃肠造影联合CT在评估食管癌放疗患者短期疗效及预后方面具有良好的应用价值。
